Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call

Rhea-AI Summary

Celldex Therapeutics (Nasdaq: CLDX) is set to announce its second quarter 2020 financial results on August 6, 2020, after market close. A conference call will follow at 4:30 p.m. EDT, where executives will discuss the financial outcomes and provide updates on ongoing research and development initiatives for the remainder of 2020. The call will be accessible via the company’s website, and a replay will be available post-event. Celldex focuses on developing targeted therapeutics for severe diseases, utilizing immunotherapies and biologics to enhance treatment options for cancer and other illnesses.

Positive

• Scheduled conference call on August 6, 2020, for Q2 financial results.
• Focus on targeted therapeutics and immunotherapies developing a robust pipeline.

Negative

• None.

HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on Thursday, August 6, 2020 after the U.S. financial markets close. Celldex executives will host a conference call at 4:30 p.m. EDT on the same day to review the second quarter  financial results and to provide an update on key research and development and business objectives for the remainder of 2020.

The conference call and presentation will be webcast live over the Internet and can be accessed by going to the "Events & Presentations" page under the "Investors & Media" section of the Celldex Therapeutics website at www.celldex.com. The call can also be accessed by dialing (800) 446-2782 (within the United States) or (847) 413-3235 (outside the United States). The passcode is 49870841.

A replay of the call will be archived on the Company's website.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com

FAQ

When will Celldex Therapeutics report its second quarter 2020 financial results?

Celldex Therapeutics will report its second quarter 2020 financial results on August 6, 2020, after the market closes.

What time is the Celldex conference call for Q2 results?

The conference call for Celldex's Q2 results is scheduled for 4:30 p.m. EDT on August 6, 2020.

How can I access the Celldex conference call?

The conference call can be accessed via the 'Events & Presentations' page on the Celldex website or by dialing the provided numbers.

What is the focus of Celldex Therapeutics?

Celldex Therapeutics is focused on developing targeted therapeutics, particularly immunotherapies, to address diseases with inadequate treatment options.